168 related articles for article (PubMed ID: 34230453)
1. Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone.
Liu S; Wu D; Sun X; Fan Y; Zha R; Jalali A; Feng Y; Li K; Sano T; Vike N; Li F; Rispoli J; Sudo A; Liu J; Robling A; Nakshatri H; Li BY; Yokota H
Bone Res; 2021 Jul; 9(1):32. PubMed ID: 34230453
[TBL] [Abstract][Full Text] [Related]
2. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
3. Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium.
Sano T; Sun X; Feng Y; Liu S; Hase M; Fan Y; Zha R; Wu D; Aryal UK; Li BY; Sudo A; Yokota H
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802279
[TBL] [Abstract][Full Text] [Related]
4. Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms.
Feng Y; Liu S; Zha R; Sun X; Li K; Robling A; Li B; Yokota H
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33450808
[TBL] [Abstract][Full Text] [Related]
5. Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity.
Lau KH; Baylink DJ; Zhou XD; Rodriguez D; Bonewald LF; Li Z; Ruffoni D; Müller R; Kesavan C; Sheng MH
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E271-81. PubMed ID: 23715728
[TBL] [Abstract][Full Text] [Related]
6. Generation of the tumor-suppressive secretome from tumor cells.
Liu S; Sun X; Li K; Zha R; Feng Y; Sano T; Dong C; Liu Y; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2021; 11(17):8517-8534. PubMed ID: 34373756
[No Abstract] [Full Text] [Related]
7. In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism.
Lara-Castillo N; Kim-Weroha NA; Kamel MA; Javaheri B; Ellies DL; Krumlauf RE; Thiagarajan G; Johnson ML
Bone; 2015 Jul; 76():58-66. PubMed ID: 25836764
[TBL] [Abstract][Full Text] [Related]
8. Preventing tumor progression to the bone by induced tumor-suppressing MSCs.
Sun X; Li K; Zha R; Liu S; Fan Y; Wu D; Hase M; Aryal UK; Lin CC; Li BY; Yokota H
Theranostics; 2021; 11(11):5143-5159. PubMed ID: 33859739
[No Abstract] [Full Text] [Related]
9. Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation.
Kang KS; Hong JM; Robling AG
Bone; 2016 Jul; 88():138-145. PubMed ID: 27143110
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between MLO-Y4 osteocytes and C2C12 muscle cells is mediated by the Wnt/β-catenin pathway.
Huang J; Romero-Suarez S; Lara N; Mo C; Kaja S; Brotto L; Dallas SL; Johnson ML; Jähn K; Bonewald LF; Brotto M
JBMR Plus; 2017 Oct; 1(2):86-100. PubMed ID: 29104955
[TBL] [Abstract][Full Text] [Related]
12. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
[TBL] [Abstract][Full Text] [Related]
13. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.
Lindvall C; Evans NC; Zylstra CR; Li Y; Alexander CM; Williams BO
J Biol Chem; 2006 Nov; 281(46):35081-7. PubMed ID: 16973609
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/β-catenin pathway.
Hua Y; Yang Y; Li Q; He X; Zhu W; Wang J; Gan X
J Biol Chem; 2018 Dec; 293(51):19710-19724. PubMed ID: 30361437
[TBL] [Abstract][Full Text] [Related]
15. Aberrant activation of Wnt signaling pathway altered osteocyte mineralization.
Zhou Y; Lin J; Shao J; Zuo Q; Wang S; Wolff A; Nguyen DT; Rintoul L; Du Z; Gu Y; Peng YY; Ramshaw JAM; Long X; Xiao Y
Bone; 2019 Oct; 127():324-333. PubMed ID: 31260814
[TBL] [Abstract][Full Text] [Related]
16. Cajanolactone A from
Liu S; Luo ZH; Ji GM; Guo W; Cai JZ; Fu LC; Zhou J; Hu YJ; Shen XL
Molecules; 2019 Jan; 24(2):. PubMed ID: 30642055
[TBL] [Abstract][Full Text] [Related]
17. Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells.
Liu S; Fan Y; Chen A; Jalali A; Minami K; Ogawa K; Nakshatri H; Li BY; Yokota H
Cancer Res; 2018 Jul; 78(14):3865-3876. PubMed ID: 29769195
[TBL] [Abstract][Full Text] [Related]
18. Mechanical tibial loading remotely suppresses brain tumors by dopamine-mediated downregulation of CCN4.
Fan Y; Zha R; Sano T; Zhao X; Liu S; Woollam MD; Wu D; Sun X; Li K; Egi M; Li F; Minami K; Siegel AP; Horiuchi T; Liu J; Agarwal M; Sudo A; Nakshatri H; Li BY; Yokota H
Bone Res; 2021 May; 9(1):26. PubMed ID: 34031366
[TBL] [Abstract][Full Text] [Related]
19. Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression.
Wang H; Deng G; Ai M; Xu Z; Mou T; Yu J; Liu H; Wang S; Li G
Oncogene; 2019 Feb; 38(9):1489-1507. PubMed ID: 30305727
[TBL] [Abstract][Full Text] [Related]
20. The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.
Yorgan TA; Peters S; Jeschke A; Benisch P; Jakob F; Amling M; Schinke T
J Bone Miner Res; 2015 Jul; 30(7):1175-83. PubMed ID: 25640331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
